Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 1;24(3):193-201.
doi: 10.4196/kjpp.2020.24.3.193.

Inhibition of Chromosomal Region Maintenance 1 Suppresses the Migration and Invasion of Glioma Cells via Inactivation of the STAT3/MMP2 Signaling Pathway

Affiliations
Free article

Inhibition of Chromosomal Region Maintenance 1 Suppresses the Migration and Invasion of Glioma Cells via Inactivation of the STAT3/MMP2 Signaling Pathway

Qianqian Shan et al. Korean J Physiol Pharmacol. .
Free article

Abstract

Chromosomal region maintenance 1 (CRM1) is associated with an adverse prognosis in glioma. We previously reported that CRM1 inhibition suppressed glioma cell proliferation both in vitro and in vivo. In this study, we investigated the role of CRM1 in the migration and invasion of glioma cells. S109, a novel reversible selective inhibitor of CRM1, was used to treat Human glioma U87 and U251 cells. Cell migration and invasion were evaluated by wound-healing and transwell invasion assays. The results showed that S109 significantly inhibited the migration and invasion of U87 and U251 cells. However, mutation of Cys528 in CRM1 abolished the inhibitory activity of S109 in glioma cells. Furthermore, we found that S109 treatment decreased the expression level and activity of MMP2 and reduced the level of phosphorylated STAT3 but not total STAT3. Therefore, the inhibition of migration and invasion induced by S109 may be associated with the downregulation of MMP2 activity and expression, and inactivation of the STAT3 signaling pathway. These results support our previous conclusion that inhibition of CRM1 is an attractive strategy for the treatment of glioma.

Keywords: Glioma; Invasion; Migration; S109; STAT3/MMP2 signaling.

Similar articles

See all similar articles
Feedback